Ontology highlight
ABSTRACT: Background
Data on drug-coated balloons (DCB) for de novo coronary chronic total occlusion (CTO) are limited. We aimed to investigate the long-term outcomes of substitution of drug-eluting stents (DES) by DCB.Methods
We compared the outcomes of less DES strategy (DCB alone or combined with DES) and DES-only strategy in treating de novo coronary CTO in this prospective, observational, multicenter study. The primary endpoints were major adverse cardiovascular events (MACE), target vessel revascularization, myocardial infarction, and death during 3-year follow-up. The secondary endpoints were late lumen loss (LLL) and restenosis until 1-year after operation.Results
Of the 591 eligible patients consecutively enrolled between January 2015 and December 2019,
SUBMITTER: Wang X
PROVIDER: S-EPMC10022494 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature